Stock Events

Stock Events

Avivagen 

$0.000100
5
+$0.00+0% Thursday 20:00

Statistics

Day High
0.0012
Day Low
0.0012
52W High
0.0012
52W Low
0.0001
Volume
100
Avg. Volume
0
Mkt Cap
7,769.4
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31DecExpected
Q1 2022
Q2 2022
Q4 2022
Q2 2023
Q1 2024
Q2 2024
Q3 2025
-0.03
-0.03
-0.02
-0.02
Expected EPS
N/A
Actual EPS
N/A

Financials

-1,810.52%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
139,043.05Revenue
-2.52MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VIVXF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zoetis
ZTS
Mkt Cap33B
Zoetis is a global leader in animal health, offering a wide range of products that compete directly with Avivagen's animal health supplements.
Elanco Animal Health
ELAN
Mkt Cap12.1B
Elanco Animal Health provides comprehensive animal health solutions, including products that overlap with Avivagen's offerings.
Idexx Laboratories
IDXX
Mkt Cap44.34B
IDEXX Laboratories specializes in diagnostics and healthcare for animals, competing in the broader animal health market alongside Avivagen.
Phibro Animal Health
PAHC
Mkt Cap1.26B
Phibro Animal Health offers a variety of animal health and nutritional products that directly compete with Avivagen's product line.
Vermilion Energy
VET
Mkt Cap1.51B
Virbac SA focuses on animal health, producing a range of products that could be seen as alternatives to Avivagen's supplements.

About

Avivagen Inc. is a life sciences firm primarily engaged in creating and distributing specialized feed supplements for livestock. These products are designed to bolster animals' immune function and contribute to their enhanced growth and overall productivity. The company's diverse product portfolio includes OxC-beta Livestock, a key additive for animal feeds, alongside canine wellness offerings such as Vivamune and Dr. Tobias dog chews. Furthermore, Avivagen provides the Dr. Tobias Beta blend, formulated to support the human immune system. With a significant international footprint, Avivagen serves customers across the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia. The company was established in 2005 and is headquartered in Ottawa, Canada.
Show more...
CEO
Mr. G. F. Kym Anthony
Employees
13
Country
Canada
ISIN
CA05382F2026

Listings

OTC Link
US
VIVXF

0 Comments

Share your thoughts

FAQ

What is Avivagen stock price today?▼
The current price of VIVXF is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Avivagen stock price performance more closely on the chart.
What is Avivagen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Avivagen stocks are traded under the ticker VIVXF.
Is Avivagen stock price growing?▼
VIVXF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Avivagen has showed a +0% increase.
What is Avivagen market cap?▼
Today Avivagen has the market capitalization of 7,769.4
What is Avivagen revenue for the last year?▼
Avivagen revenue for the last year amounts to 139,043.05 USD.
What is Avivagen net income for the last year?▼
VIVXF net income for the last year is -2.52M USD.
How many employees does Avivagen have?▼
As of June 26, 2026, the company has 13 employees.
In which sector is Avivagen located?▼
Avivagen operates in the Health & Wellness sector.
When did Avivagen complete a stock split?▼
The last stock split for Avivagen was on May 25, 2017 with a ratio of 1:10.
Where is Avivagen headquartered?▼
Avivagen is headquartered in Ottawa, Canada.